Genertec Universal Medical Group Company Limited Cash Flow Reinvestment Rate
Genertec Universal Medical Group Company Limited cash flow reinvestment rate. Genertec Universal Medical Group Company Limited (5UM) has a Cash Flow Reinvestment Rate of 0.11x as of December 2022, reinvesting €184.52 Million (capex €170.49 Million plus investments €-14.03 Million) from operating cash flow of €1.69 Billion. Explore how well can Genertec Universal Medical Group Company service its debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Genertec Universal Medical Group Company Limited (2022–2025)
Cash flow reinvestment rate of Genertec Universal Medical Group Company Limited from 2022 to 2025. Historical reinvestment intensity for Genertec Universal Medical Group Company Limited across 4 annual periods. Explore capital reinvestment ratio of Genertec Universal Medical Group Company to see what proportion of operating cash flow is directed to capital expenditures.
Genertec Universal Medical Group Company Limited Cash Flow Reinvestment Rate by Year (2022–2025)
Genertec Universal Medical Group Company Limited cash flow reinvestment rate by year from 2022 to 2025. Year-by-year capital reinvestment analysis for Genertec Universal Medical Group Company Limited. For the full cash flow conversion analysis, see cash efficiency ratio of Genertec Universal Medical Group Company.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.17x | €1.01 Billion | €5.78 Billion | €988.91 Million | ▼ -87.9% |
| 2024 | 1.44x | €1.64 Billion | €1.14 Billion | €1.26 Billion | ▲ +267.1% |
| 2023 | 0.39x | €1.96 Billion | €4.99 Billion | €896.83 Million | ▲ +4.0% |
| 2022 | 0.38x | €774.64 Million | €2.06 Billion | €608.09 Million | — |